Document is current
Any future updates will be listed below
-
Authors
Strand, Vibeke
Boklage, Susan H.
Kimura, Toshio
Joly, Florence
Boyapati, Anita
Msihid, Jérôme
-
Funding
Funding for this research was provided by:
Sanofi
Regeneron Pharmaceuticals
- License Information
-
More Information
Article History
Received: 7 April 2020
Accepted: 5 October 2020
First Online: 20 October 2020
Ethics approval and consent to participate
: The MONARCH study was approved by the ethical committee of the Institutional Review Board of recruitment sites. The reference number for the study is ExternalRef removed identifier NCT02332590.
: Not applicable.
: Vibeke Strand is a consultant for AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celltrion, CORRONA, Crescendo, Genentech/Roche, GlaxoSmithKline, Janssen, Eli Lilly, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Sandoz, Sanofi, and UCB. Toshio Kimura and Anita Boyapati are employees of, and shareholders in, Regeneron Pharmaceuticals, Inc. Susan Boklage was an employee and shareholder in Regeneron Pharmaceuticals, Inc. during the preparation of the manuscript. Florence Joly and Jerome Msihid are employees of, and shareholders in, Sanofi.
